Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Covington
Dow
Farmers Insurance
Fuji
Chubb
Moodys
Argus Health

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021212

« Back to Dashboard

NDA 021212 describes CAVERJECT IMPULSE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the CAVERJECT IMPULSE profile page.

The generic ingredient in CAVERJECT IMPULSE is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
Summary for 021212
Pharmacology for NDA: 021212
Medical Subject Heading (MeSH) Categories for 021212
Suppliers and Packaging for NDA: 021212
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212 NDA Pharmacia and Upjohn Company LLC 0009-5181 N 0009-5181-01
CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212 NDA Pharmacia and Upjohn Company LLC 0009-5182 N 0009-5182-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.01MG/VIAL
Approval Date:Jun 11, 2002TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.02MG/VIAL
Approval Date:Jun 11, 2002TE:RLD:No

Expired US Patents for NDA 021212

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Moodys
US Army
Johnson and Johnson
Fuji
Boehringer Ingelheim
Healthtrust
Daiichi Sankyo
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.